v2.3.0.11
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands
6 Months Ended
Jun. 25, 2011
Jun. 26, 2010
Cash flows from operating activities:    
Net income $ 188,027 $ 160,415
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 57,469 50,344
Amortization of bond discount 0 3,135
Stock-based compensation expense 17,960 12,999
Provision for losses on trade and other accounts receivable 2,722 2,322
Benefit from deferred income taxes (10,265) (5,831)
Undistributed earnings of affiliates (5,786) (3,326)
Other 2,242 2,649
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable (9,902) (33,854)
Inventories 3,902 32,264
Other current assets (11,100) (18,411)
Accounts payable and accrued expenses (49,977) (73,718)
Net cash provided by operating activities 185,292 128,988
Cash flows from investing activities:    
Purchases of fixed assets (20,764) (17,542)
Payments for equity investments and business acquisitions, net of cash acquired (143,636) (204,598)
Purchases of available-for-sale securities 0 (26,984)
Proceeds from sales of available-for-sale securities 2,150 1,400
Proceeds from maturities of available-for-sale securities 0 11,996
Other 230 307
Net cash used in investing activities (162,020) (235,421)
Cash flows from financing activities:    
Proceeds from (repayments of) bank borrowings 7,671 (668)
Proceeds from issuance of long-term debt 3,101 0
Principal payments for long-term debt (23,916) (50,175)
Proceeds from issuance of stock upon exercise of stock options 27,938 21,036
Payments for repurchases of common stock (32,098) 0
Excess tax benefits related to stock-based compensation 6,852 6,351
Distributions to noncontrolling shareholders (6,417) (7,736)
Acquisitions of noncontrolling interests in subsidiaries (3,366) (10,000)
Other (90) (180)
Net cash used in financing activities (20,325) (41,372)
Net change in cash and cash equivalents 2,947 (147,805)
Effect of exchange rate changes on cash and cash equivalents 8,494 (2,233)
Cash and cash equivalents, beginning of period 150,348 471,154
Cash and cash equivalents, end of period $ 161,789 $ 321,116